Odaberite jezik

hr
  • bg

  • cs

  • da

  • de

  • el

  • en

  • es

  • et

  • fr

  • hr

  • hu

  • it

  • lt

  • lv

  • nl

  • no

  • pl

  • pt

  • ro

  • ru

  • sk

  • sl

  • sv

  • tr

  • uk

Hrvatski
  • Български

  • Čeština

  • Danske

  • Deutsch

  • ελληνική

  • English

  • Español

  • Eesti keel

  • Français

  • Hrvatski

  • Magyar

  • Italiano

  • Lietuvių

  • Latviešu

  • Nederlands

  • Norsk

  • Polski

  • Português

  • Română

  • Русский

  • Slovenský

  • Slovenski

  • Svenska

  • Türkçe

  • Українська

Koja nadoplata na račun vam bolje odgovara?

* Ne naplaćujemo proviziju za polaganje depozita na vaš račun

Gilead Sciences

GILD.US $ 67.76 USD

-0.31 $ (-0.46%)

Potencijal rasta

10.01%

Prihod od dividende

3.49%

1d
1t
1 mj.
6 mjes.
Cijelo vrijeme

Dodaj u košaricu

1 serija = 1 dionica

Iznos kupnje:

Brokerska provizija:

Provizija za prijenos:

Preporuka

Strong Buy

Rejting uspješnosti

DCF

73.28

ROE

0.01

ROA

-

P/S

3.33

P/B

4.52

Debt / Equity

1.57

Korporativne informacije

Gilead Sciences is the largest American biopharmaceutical company engaged in research and development of healthcare products and has a batch production of innovative medicines. The Company was founded in 1987 by a 29-year-old doctor Michael L. Riordan. Gilead's technologies, as well as the drugs themselves, have established themselves as a leading choice when it comes to prevention and cure of the most fatal human diseases. The Company's main efforts have been focused on HIV cure development as well as various treatments of chronic hepatitis B and C, cancers, cardiovascular and respiratory diseases. Among the well-known products are Tamiflu, Atripla, Vistide, Emtriva. The latest successful project of Gilead was Sovaldi, which is an effective medicine for hepatitis C cure. The innovation has become an all-time record of sales. The company's research centers are located in the American cities of Boulder and San Dimas. The company has a rather small staff number, which is about 8,000 employees, with a fairly large turnover of almost $ 25 billion. Today Gilead Sciences boasts of being one of the most speedily developing start-ups in its field. Its headquarters are in California, though the company has its representative offices in other states of North America, as well as in Europe, Asia, and Australia.


Prijavite se kako biste primali ideje za ulaganje analitičara društva Freedom Finance

Jedanput tjedno slat ćemo Vam poruku e-pošte koja sadrži samo najrelevantnije i najvažnije informacije

Čestitamo!

Sada ćete uvijek biti svjesni u koje dionice je isplativije ulagati